Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
D000328:Adult; D000341:Affective Disorders, Psychotic / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000188:drug therapy / Q000503:physiopathology; D003866:Depressive Disorder / Q000503:physiopathology; D004723:Endorphins / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D008875:Middle Aged; D009270:Naloxone / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use*; D011388:Prolactin / Q000097:blood; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology
D004723:Endorphins; D009294:Narcotics; D009270:Naloxone; D011388:Prolactin; D008691:Methadone; D006854:Hydrocortisone